Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

May 1, 1999; Volume 40,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Fukuchi, Kazuki

    1. You have access
      Applicability of 99mTc-HL91, a Putative Hypoxic Tracer, to Detection of Tumor Hypoxia
      Kenji Yutani, Hideo Kusuoka, Kazuki Fukuchi, Mitsuaki Tatsumi and Tsunehiko Nishimura
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 854-861;
  2. Gardin, Isabelle

    1. You have access
      Use of Subtraction Ictal SPECT Co-Registered to MRI for Optimizing the Localization of Seizure Foci in Children
      Pierre Véra, Anna Kaminska, Cécile Cieuta, Andreas Hollo, Jean Louis Stiévenart, Isabelle Gardin, Dorothé Ville, Jean François Mangin, Perrine Plouin, Olivier Dulac and Catherine Chiron
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 786-792;
  3. Germano, Guido

    1. You have access
      On the Accuracy and Reproducibility of Quantitative Gated Myocardial Perfusion SPECT
      Guido Germano and Daniel S. Berman
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 810-813;
  4. Gillham, Ruth

    1. You have access
      Regional Cerebral Perfusion and Amytal Distribution During the Wada Test
      Rajith de Silva, Roderick Duncan, James Patterson, Ruth Gillham and Donald Hadley
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 747-752;
  5. Glover, David K.

    1. You have access
      Assessment of Myocardial Viability Using 123I-Labeled Iodophenylpentadecanoic Acid at Sustained Low Flow or After Acute Infarction and Reperfusion
      Joo Y. Yang, Mirta Ruiz, Dennis A. Calnon, Denny D. Watson, George A. Beller and David K. Glover
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 821-828;
  6. Gonzalez, Joaquín

    1. You have access
      99mTc-Labeled Antihuman Epidermal Growth Factor Receptor Antibody in Patients with Tumors of Epithelial Origin: Part III. Clinical Trials Safety and Diagnostic Efficacy
      Mayra Ramos-Suzarte, Nelson Rodríguez, Juan P. Oliva, Normando Iznaga-Escobar, Alejandro Perera, Alejo Morales, Niurka Gonzalez, Maria Cordero, Leonel Torres, Gilmara Pimentel, Mercedes Borrón, Joaquín González, Olga Torres, Teresita Rodríguez and Rolando Pérez
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 768-775;
  7. Gonzalez, Niurka

    1. You have access
      99mTc-Labeled Antihuman Epidermal Growth Factor Receptor Antibody in Patients with Tumors of Epithelial Origin: Part III. Clinical Trials Safety and Diagnostic Efficacy
      Mayra Ramos-Suzarte, Nelson Rodríguez, Juan P. Oliva, Normando Iznaga-Escobar, Alejandro Perera, Alejo Morales, Niurka Gonzalez, Maria Cordero, Leonel Torres, Gilmara Pimentel, Mercedes Borrón, Joaquín González, Olga Torres, Teresita Rodríguez and Rolando Pérez
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 768-775;
  8. Hadley, Donald

    1. You have access
      Regional Cerebral Perfusion and Amytal Distribution During the Wada Test
      Rajith de Silva, Roderick Duncan, James Patterson, Ruth Gillham and Donald Hadley
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 747-752;
  9. Hambye, Anne-Sophie E.

    1. You have access
      Influence of Methodology on the Presence and Extent of Mismatching Between 99mTc-MIBI and 123I-BMIPP in Myocardial Viability Studies
      André A. Dobbeleir, Anne-Sophie E. Hambye and Philippe R. Franken
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 707-714;
  10. Hemelaar, Jos T.G.M.

    1. You have access
      One-Day Protocol for Imaging of the Nigrostriatal Dopaminergic Pathway in Parkinson's Disease by [123I]FPCIT SPECT
      Jan Booij, Jos T.G.M. Hemelaar, Johannes D. Speelman, Kora de Bruin, Anton G.M. Janssen and Eric A. van Royen
      Journal of Nuclear Medicine May 1, 1999, 40 (5) 753-761;
« Previous (Pages : 2 3 4 5 6 7 8 9 10 11 ... 17) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 40, Issue 5
May 1, 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire